SCGB1A1 and asthma: Clara cell secretory protein 10 (CC10) demonstrated reduced expression in AR models, while treatment with recombinant CC10 attenuated allergic airway inflammation in a mouse model of asthma, suggesting its potential as both a therapeutic and a biomarker [26,27].